These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25595209)

  • 1. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
    Lanas A; Gargallo CJ
    J Gastroenterol; 2015 Jun; 50(6):626-37. PubMed ID: 25595209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Valkhoff VE; Sturkenboom MC; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
    Iijima K; Shimosegawa T
    Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-platelet therapy and managing ulcer risk.
    Chan FK
    J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirin.
    Chan FK
    Drugs; 2006; 66 Suppl 1():23-8; discussion 29-33. PubMed ID: 16869345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
    Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
    Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
    Bretagne JF
    Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
    Bae SE; Kim SE; Jung SA; Yoon SY; Shim KN; Jung HK; Kim TH; Yoo K; Moon IH
    Korean J Gastroenterol; 2011 Apr; 57(4):213-20. PubMed ID: 21519174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Lanas A
    Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
    Leung Ki EL; Chan FK
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin.
    Hsu PI; Tsai TJ
    Curr Pharm Des; 2015; 21(35):5049-55. PubMed ID: 26369688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
    Peura DA; Wilcox CM
    Postgrad Med; 2014 Jan; 126(1):87-96. PubMed ID: 24393755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.